NextCell Pharma ABNXTCL 
$0.16-2.40%24h
-2.40%24h
Global rank34314
Market cap$5.49M
Change 7d24.43%
YTD Performance-38.02%
SP500 benchmarkUnderperform
P/E-0.14
P/S5.54
Revenue$990.69K
Earnings-$3.90M
Dividend yield-
Main Sector
Healthcare
Category
EPS for NextCell Pharma AB (NXTCL)
NextCell Pharma AB has an EPS of $-1.158004. In 2022, the company made an earnings per share (EPS) of $-1.034171. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for NXTCL
-
Value:-
EPS history for NextCell Pharma AB from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$1.16 | 11.97% |
| 2022 | -$1.03 | 44.78% |
| 2021 | -$0.714284 | 5.44% |
| 2020 | -$0.677435 | - |
View the highest EPS stocks
